Home / Health / Rajasthan Bans 7 Pharma Firms, 40 Medicines for Quality Failures
Rajasthan Bans 7 Pharma Firms, 40 Medicines for Quality Failures
21 Nov
Summary
- Seven pharmaceutical firms and 40 medicines banned for failing quality standards.
- This action represents the largest ban since the Rajasthan Medical Services Corporation's inception.
- A robust quality-testing mechanism is in place to prevent substandard medicines from reaching hospitals.
Rajasthan's Medical and Health Department is intensifying its focus on healthcare quality with a zero-tolerance policy for negligence. The Rajasthan Medical Services Corporation (RMSC) has debarred seven firms and 40 medicines this year due to quality failures, the most significant action since its establishment. This reflects a commitment to ensuring only standard-quality medicines are supplied under the Chief Minister's Free Medicine Scheme.
The RMSC has implemented a robust quality-testing mechanism. Medicines are quarantined upon arrival and undergo rigorous testing by authorized laboratories before release. Batches failing initial tests are sent for confirmation, and independent samples are also collected by drug control officers. Firms found in violation face penalties, debarment, or blacklisting after a hearing process.
This year's actions include debarring five firms for five years and two for three years for supplying substandard or adulterated medicines and violating service conditions. Additionally, 40 medicines have been banned from sale and marketing after testing confirmed they were substandard. This comprehensive crackdown aims to safeguard public health by eradicating substandard pharmaceutical products.
